Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Fraud's not that big of a deal: the Valeant story, according to Bill Ackman
Fierce editors discuss the latest turns in the Valeant Pharmaceuticals saga, the seeming inevitability of a Pfizer-Allergan merger, and Shire's up-and-down efforts to buy stuff it wants.
About This Episode
Fraud's not that big of a deal: the Valeant story, according to Bill Ackman is an episode from FierceBiotech Radio. Fierce editors discuss the latest turns in the Valeant Pharmaceuticals saga, the seeming inevitability of a Pfizer-Allergan...
Podcast
This episode belongs to FierceBiotech Radio.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Nov 5, 2015, 29:46 long, audio available.
Related Episodes
Continue listening to more episodes from FierceBiotech Radio.
